Global Patent Index - EP 2109454 A1

EP 2109454 A1 20091021 - GLP-1 PHARMACEUTICAL COMPOSITIONS

Title (en)

GLP-1 PHARMACEUTICAL COMPOSITIONS

Title (de)

PHARMAZEUTISCHE GLP-1-ZUSAMMENSETZUNGEN

Title (fr)

COMPOSITIONS PHARMACEUTIQUES À BASE DE GLP-1

Publication

EP 2109454 A1 20091021 (EN)

Application

EP 07868132 A 20071231

Priority

  • US 2007026490 W 20071231
  • US 64774606 A 20061229
  • US 90058607 A 20070912

Abstract (en)

[origin: WO2008082656A1] The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.

IPC 8 full level

A61K 31/70 (2006.01); A61K 38/26 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01)

CPC (source: EP KR)

A61K 9/0019 (2013.01 - EP); A61K 31/70 (2013.01 - EP); A61K 33/30 (2013.01 - KR); A61K 33/34 (2013.01 - KR); A61K 38/26 (2013.01 - EP KR); A61K 47/02 (2013.01 - EP); A61K 47/12 (2013.01 - EP); A61P 3/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/28 (2017.12 - EP)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR MK RS

DOCDB simple family (publication)

WO 2008082656 A1 20080710; AU 2007340369 A1 20080710; AU 2007340369 B2 20111222; AU 2007340369 C1 20130502; CN 101668535 A 20100310; CN 101668535 B 20170728; EP 2109454 A1 20091021; EP 2109454 A4 20130605; JP 2010523473 A 20100715; KR 101247665 B1 20130402; KR 20090096739 A 20090914

DOCDB simple family (application)

US 2007026490 W 20071231; AU 2007340369 A 20071231; CN 200780051882 A 20071231; EP 07868132 A 20071231; JP 2009544117 A 20071231; KR 20097015759 A 20071231